Literature DB >> 19234151

Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells.

Susan Kohlhaas1, Oliver A Garden, Cheryl Scudamore, Martin Turner, Klaus Okkenhaug, Elena Vigorito.   

Abstract

Foxp3 is a transcription factor that is essential for the normal development of regulatory T cells (Tregs). In the absence of microRNAs (miRNAs), Foxp3(+) Tregs develop but fail to maintain immune homeostasis, leading to a scurfy-like disease. Global analysis of the network of genes regulated by Foxp3 has identified the miRNA miR-155, which is highly expressed in Tregs, as a direct target of Foxp3. In this study we report that miR-155-deficient mice have reduced numbers of Tregs, both in the thymus and periphery, due to impaired development. However, we found no evidence for defective suppressor activity of miR-155-deficient Tregs, either in vitro or in vivo. Our results indicate that miR-155 contributes to Treg development, but that additional miRNAs control Treg function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234151     DOI: 10.4049/jimmunol.0803162

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  195 in total

1.  MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis.

Authors:  Ankita Singh; Pradeepta Sekhar Patro; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2018-12-03       Impact factor: 2.980

Review 2.  Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.

Authors:  Wolfgang Poller; Madlen Rother; Carsten Skurk; Carmen Scheibenbogen
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  microRNAs at the regulatory frontier: an investigation into how microRNAs impact the development and effector functions of CD4 T cells.

Authors:  Erik Allen Lykken; Qi-Jing Li
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

4.  MicroRNA-17 Modulates Regulatory T Cell Function by Targeting Co-regulators of the Foxp3 Transcription Factor.

Authors:  Huang-Yu Yang; Joseph Barbi; Chao-Yi Wu; Ying Zheng; Paolo D A Vignali; Xingmei Wu; Jin-Hui Tao; Benjamin V Park; Shashika Bandara; Lewis Novack; Xuhao Ni; Xiaoping Yang; Kwang-Yu Chang; Ren-Chin Wu; Junran Zhang; Chih-Wei Yang; Drew M Pardoll; Huabin Li; Fan Pan
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

Review 5.  MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases.

Authors:  Rujuan Dai; S Ansar Ahmed
Journal:  Transl Res       Date:  2011-02-01       Impact factor: 7.012

6.  MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.

Authors:  Nina C Zitzer; Katiri Snyder; Xiamoei Meng; Patricia A Taylor; Yvonne A Efebera; Steven M Devine; Bruce R Blazar; Ramiro Garzon; Parvathi Ranganathan
Journal:  J Immunol       Date:  2018-05-02       Impact factor: 5.422

Review 7.  MicroRNAs in immune response and macrophage polarization.

Authors:  Gang Liu; Edward Abraham
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

Review 8.  Potential function of miRNAs in herpetic stromal keratitis.

Authors:  Sachin Mulik; Siddheshvar Bhela; Barry T Rouse
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-17       Impact factor: 4.799

9.  Liver microRNA Profile of Induced Allograft Tolerance.

Authors:  Matthew James Vitalone; Liang Wei; Masato Fujiki; Audrey H Lau; Erik Littau; Carlos Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2016-04       Impact factor: 4.939

10.  MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.

Authors:  Mary E Severin; Priscilla W Lee; Yue Liu; Amanda J Selhorst; Matthew G Gormley; Wei Pei; Yuhong Yang; Mireia Guerau-de-Arellano; Michael K Racke; Amy E Lovett-Racke
Journal:  Brain       Date:  2016-04-28       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.